Adverse events at end of · patients with chronic obstructive pulmonary disease
Vapour ablation showed no clear difference in adverse events at end of compared with control (moderate certainty).
1 finding from 1 review
Cost‐effectiveness · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Meters change from baseline in 6MWD · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Adverse events at end of · patients with chronic obstructive pulmonary disease
AeriSeal probably leads to higher adverse events at end of compared with control (moderate certainty).
1 finding from 1 review
Cost‐effectiveness · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
FEV1 % predicted: relative change from baseline · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Mortality at end of · patients with chronic obstructive pulmonary disease
Airway bypass stents showed no clear difference in mortality at end of compared with control (moderate certainty).
1 finding from 1 review
Hospitalisations for COPD/100 patient‐years (action plan + phone · acute exacerbations of chronic obstructive pulmonary disease
Action plan showed no clear difference in hospitalisations for COPD/100 patient‐years (action plan + phone compared with usual care (moderate certainty).
1 finding from 1 review
Hospitalisations and emergency visits for COPD/100 patient‐years (action plan + phone · acute exacerbations of chronic obstructive pulmonary disease
Action plan leads to lower hospitalisations and emergency visits for COPD/100 patient‐years… compared with usual care (high certainty).
1 finding from 1 review
Hospital admissions · acute exacerbations of chronic obstructive pulmonary disease
Action plan probably leads to lower at least 1 hospital admission compared with usual care (moderate certainty).
1 finding from 1 review
Mortality (all‐cause) · acute exacerbations of chronic obstructive pulmonary disease
Action plan showed no clear difference in mortality (all‐cause) compared with usual care (moderate certainty).
1 finding from 1 review
Courses of oral corticosteroids · acute exacerbations of chronic obstructive pulmonary disease
1 finding from 1 review
Number of courses of antibiotics · acute exacerbations of chronic obstructive pulmonary disease
1 finding from 1 review
Quality of life St George's Respiratory Questionnaire (SGRQ) score · acute exacerbations of chronic obstructive pulmonary disease
1 finding from 1 review
Depression score · acute exacerbations of chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Postoperative mortality · people with surgical treatment for periampullary or pancreatic carcinoma
The intervention showed no clear difference in postoperative mortality (moderate certainty).
1 finding from 1 review
Intervention not reported
Pancreatic fistula · people with surgical treatment for periampullary or pancreatic carcinoma
The intervention showed no clear difference in pancreatic fistula (low certainty).
1 finding from 1 review
Intervention not reported
DGE · people with surgical treatment for periampullary or pancreatic carcinoma
The intervention may leads to higher DGE (low certainty).
1 finding from 1 review
Intervention not reported
Overall survival · people with surgical treatment for periampullary or pancreatic carcinoma
The intervention showed no clear difference in overall survival (low certainty).
1 finding from 1 review
Intervention not reported
Intraoperative blood loss (millilitres) · people with surgical treatment for periampullary or pancreatic carcinoma
The intervention showed no clear difference in intraoperative blood loss (millilitres) (low certainty).
1 finding from 1 review